Skip to main content

Table 2 Data of the 2011–2018 CF NBS algorithm: IRT1/IRT2 + LACT protocol and IRT1/DNA protocol separately

From: Cystic fibrosis in Tuscany: evolution of newborn screening strategies over time to the present

 

CF NBS 2011–2018

IRT1/IRT2 + LACT

IRT1/DNA

IRT1/IRT2 + LACT + IRT1/DNA (actual strategy)

Newborns screened for CF

231,845

231,845

231,845

Newborns with negative screening

231,370

231,604

231,227

Non CF newborns with negative screening (TNs)

231,362

231,599

231,225

Number of retesting (IRT2)

906

906

Number of sweat tests (newborns with positive screening)

475

241

618

Number of sweat tests after positive IRT1 + LACT

157

Number of sweat tests after positive retesting (IRT2)

318

Non CF newborns with positive screening (FPs)

430

194

568

CF newborns with positive screening (TPs)

44

47

50

CF newborns with negative screening (FNs)

8

5

2

CF newborns diagnosed for meconium ileus

7

7

7

Sensitivity (%)

84.61a

90.38a

96.15

Specificity (%)

99.81a

99.91a

99.75

Positive predictive value (%)

9.26a

19.50a

8.09

Negative predictive value (%)

99.99a

99.99a

99.99

  1. aThese values are different from those of Table 2 of Terlizzi et al (2019) [22] because our analysis covered 1 year longer (2011–2018 vs. 2011–2017)